Allogene Therapeutics (ALLO) Net margin US GAAP (year values)
FY2020 FY2021 FY2022 FY2023 FY2024   LTM ? CAGR 5 years ?
Net margin, % ? -159.6% -218 214% -344 489% -1 170 864%    
Changes by years, y/y, % -218 055pp -126 275pp -826 374pp     +1 843.2%
Compare with other companies

Allogene Therapeutics. Net margin, %

Allogene Therapeutics. Net margin, changes, pp

Allogene Therapeutics (ALLO) Net margin US GAAP (quarter values)
FY2023Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2024Q1   LTM ?
Net margin, % ? -333 227% -360 145% -283 123% -202 857% -295 455%  
Changes by years, y/y, % -202 325pp -273 184pp -113 433pp -1 055pp +37 772pp    
Changes by quarters, q/q, % -131 425pp -26 919pp +77 023pp +80 266pp -92 598pp    

Allogene Therapeutics. Net margin, %

Allogene Therapeutics. Net margin, changes, pp

Allogene Therapeutics. Net margin, changes, pp


Have an idea?
Blogs All blogs wire
Most useful
Most commented
NEWS
Trade Signals
Answers to questions
Books reviews
Corporate blogs
Forums All forums wire
Common
Stocks
Algotrading
Options
Cryptocurrencies
Forex
Brokers rating
Stocks Heat Map
Quotes
Fundamental analysis
Financials
Dividends
My portfolio
All companies
Stocks Calendar
Smartlab Smartlab Values
SiteMap
Ads
Contacts

Rules
Help
Feedback
Moscow Exchange is the source and the owner of marketdata. The users haven't right of further distribution or presentation of any data without written permission of Moscow Exchange, haven't right to create modified information for further public distribution to third parties.